We recently published 12 Best Healthcare Stocks to Buy Under $30. MannKind Corporation (NASDAQ:MNKD) is one of the best ...

MannKind Corporation (MNKD) said on Wednesday that it has entered into up to $500 million strategic financing agreement with ...

MannKind (NASDAQ:MNKD), a biopharmaceutical firm known for its inhaled insulin and pulmonary therapeutics, released its second quarter 2025 earnings on August 6, 2025. The most si ...

MannKind Corporation (NASDAQ:MNKD) is one of the penny stocks that will skyrocket. On July 16, H.C. Wainwright assumed coverage of the stock with a ‘Buy’ rating and a $9 price target. The bullish ...

Analysts anticipate MannKind to report an earnings per share (EPS) of $0.06. The announcement from MannKind is eagerly ...

Investors in MannKind Corp (Symbol: MNKD) saw new options become available today, for the October 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD ...

Strengthens MannKind’s capital structure with flexible, long-term, non-dilutive fundingMannKind to receive $75 million in cash at closing DANBURY, Conn. and WESTLAKE VILLAGE, Calif. and NEW YORK, Aug.

MannKind saw decent growth from its two core products in Q2 and just signed a new non-dilutive financing agreement with ...

MannKind Corporation (NASDAQ: MNKD) is one of the best biotech penny stocks to buy right now. Analyst Yun Zhong from Wedbush ...

Investors in MannKind Corp (Symbol: MNKD) saw new options begin trading today, for the March 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD ...

Investors in MannKind Corp (NASD: MNKD) saw new options become available today, for the January 2014 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD ...